Oral dosage formulations of protease resistant polypeptides

Details Oral dosage formulations of protease resistant polypeptides Oral dosage formulations of protease resistant polypeptides

A - Human Necessities

61

K

A61K 38/27 (2006.01) A61K 9/28 (2006.01) A61K 9/52 (2006.01) A61K 31/7056 (2006.01) A61K 38/17 (2006.01) A61K 38/21 (2006.01)

Patent

CA 2583716

Oral dosage formulations of t protease-resistant therapeutic polypeptides are provided. The dosage formulations for administration per dosage per day or per week are higher than the subcutaneous dosage. Included among the oral dosage formulations are tablets and capsules, including enteric-coated forms. Methods for treatment or prevention of diseases or conditions that are treatable or preventable by the administration of such oral dosage formulations of protease-resistant polypeptides are provided.

Affiliated with

Also associated with

Rating

Oral dosage formulations of protease resistant polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral dosage formulations of protease resistant polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral dosage formulations of protease resistant polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1371615